Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers.

Aims: Mizoribine is an oral immunosuppressive agent approved in several countries for prevention of rejection in renal transplantation. Its therapeutic window is based on trough concentrations staying at > or =0.5 but <3 microg ml(-1).